Preclinical Safety Assessment
The goal of preclinical safety assessment should be to provide some assurance that patients will be protected from any unacceptable risks by defining safe and active doses. These data have been useful in providing some assurance that severe adverse effects would not be induced in patients.
For more: http://www.globalepisteme.org/Conference/toxicology-pharmacology-conference/
For abstract submission: http://www.globalepisteme.org/Conference/toxicology-pharmacology-conference/submitabstract
Contact us: toxicology@globalepisteme.com
For more: http://www.globalepisteme.org/Conference/toxicology-pharmacology-conference/
For abstract submission: http://www.globalepisteme.org/Conference/toxicology-pharmacology-conference/submitabstract
Contact us: toxicology@globalepisteme.com
Comments
Post a Comment